Status:
COMPLETED
Novel Technique for Botulinum Toxin Injection to Minimize Patient Discomfort
Lead Sponsor:
Henry Ford Health System
Conditions:
Pain
Eligibility:
FEMALE
25-55 years
Phase:
NA
Brief Summary
This single blinded randomized pilot study was performed on 21 Caucasian females to determine if injections through follicular openings were less painful than traditional injections for cosmetic botul...
Detailed Description
Objective: To investigate whether injection of botulinum toxin type A is less painful if performed through follicular openings versus traditional non-specific approach. Design: Prospective, randomize...
Eligibility Criteria
Inclusion
- Female
- No prior history of botulinum toxin
- Age 25-55
Exclusion
- Male
- Prior history of botulinum toxin
- Neuromuscular disorders
- Aminoglycoside therapy
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00628472
Start Date
January 1 2007
End Date
May 1 2007
Last Update
April 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health System
Detroit, Michigan, United States, 48202